Clinical Characteristics of Turkish Women withCandida kruseiVaginitis and Antifungal Susceptibility of theC. kruseiIsolates
Authors:
Open Access
- 11 December 2013
- journal article
- research article
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2013, 1-7
Abstract
Objective.Candida kruseicauses approximately 1% of vulvovaginal candidiasis (VVC) cases and is naturally resistant to fluconazole. Antifungal testing may be required ifC. kruseivaginitis fails to respond to non-fluconazole therapy, particularly in patients with recurrent infections.Design. We investigated the clinical characteristics and antifungal susceptibility profile of vaginalC. kruseiisolates. Between 2009 and 2012, we identified 560 unrelatedCandidaspp.-positive vaginal cultures, of which 28 (5.0%) wereC. krusei. These isolates were analyzed according to host factors and the clinical forms of VVC, and theirin vitrosusceptibility to 10 antifungal agents was tested using a reference microdilution method.Results. We observed that perineal laceration and increased age (>50 years) were significant predictors ofC. kruseiin vaginal samples (). All isolates were susceptible to amphotericin B, caspofungin, ketoconazole, and miconazole. Additionally, susceptible dose-dependent and resistant rates were found for fluconazole as 42.9% and 57.1%, respectively. Remarkably, only 42.9% and 67.9% of the isolates were susceptible to itraconazole and voriconazole, respectively.Conclusions. Understanding local susceptibility patterns, especially those of non-C. albicans Candidaspecies, can significantly aid in the selection of an effective antifungal agent. Thein vivoresponse ofC. kruseivaginitis to various antifungal therapeutics remains unknown and requires further research.
Keywords
Funding Information
- Çukurova University in Adana, Turkey
- Gazi University in Ankara, Turkey
This publication has 15 references indexed in Scilit:
- Fluconazole-Resistant Candida albicans VulvovaginitisObstetrics & Gynecology, 2012
- Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Journal of Clinical Microbiology, 2008
- Vulvovaginal candidosisThe Lancet, 2007
- Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent CasesJournal of Clinical Microbiology, 2005
- Vaginal Candida parapsilosis: Pathogen or Bystander?2005
- Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical ImplicationsAntimicrobial Agents and Chemotherapy, 2003
- Vaginitis Due toCandida krusei:Epidemiology, Clinical Aspects, and TherapyClinical Infectious Diseases, 2002
- Determinants of different Candida species infections of the genital tract in womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2000
- Chronic fungal vaginitis: The value of culturesAmerican Journal of Obstetrics and Gynecology, 1995
- Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic.Journal of Clinical Pathology, 1991